menu search

Angle says study shows parsortix can select patients most suitable for immunotherapy treatments

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Pa...

January 21, 2022, 3:30 am

Angle says study shows parsortix can select patients most suitable for immunotherapy treatments

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Pa...

January 21, 2022, 3:30 am

Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...

January 21, 2022, 2:59 am

Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...

January 21, 2022, 2:59 am

Angle hails study where parsortix showed ability to help select patients for immunotherapy treatments

ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed how its...

January 21, 2022, 2:59 am

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Clovis oncology is now discounted and offers a great risk-reward

Clovis Oncology has had a rough 2021, with Rubraca sales continuing to disappoint. The company's Q3 sales revealed a slight increase quarter-over-quar...

December 30, 2021, 1:17 pm

Why immunogen stock is flying high today

The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...

December 1, 2021, 1:25 pm

Why immunogen stock is flying high today

The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...

December 1, 2021, 1:25 pm

Why immunogen stock is flying high today

The biotech is continuing to surge after after a late-stage win in treatment for advanced ovarian cance...

December 1, 2021, 1:25 pm

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...

October 7, 2021, 3:29 pm

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...

October 7, 2021, 3:29 pm

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-escala...

October 7, 2021, 3:29 pm


Search within

Pages Search Results: